which already has an FDA green light for its Igalmi (dexmedetomidine) drug in agitation associated with schizophrenia and bipolar disorder, and has a phase 3 programme running in Alzheimer’s ...
If the European Medicines Agency takes an overly cautious approach to selecting specialists to advise on new medicines, ...
A chemist a UAlbany and his son are looking to make a major breakthrough in the world of Alzheimer's prevention. They believe ...
The new Alzheimer’s drug Kinsula is offering hope for patients by slowing down the progression of the disease. Neurologist Dr. Mauricio Concha administered the drug ...
According to the FDA, the drug is approved for people with early symptomatic Alzheimer’s disease, which includes mild cognitive impairment and those with the mild dementia stage of Alzheimer’s ...
Hoping to skirt the slow pace of new drug development, researchers are leaning on AI to uncover fresh uses for known ...
After a lull of nearly 2 decades, the Food and Drug Administration (FDA) has approved some ... a third of people living with dementia in the UK don’t get a diagnosis at all.
Leqembi, an Alzheimer's drug from Biogen and Eisai, faces hurdles with respect to reimbursement and diagnostic uncertainties, diagnostic test requirements and the need for regular brain scans, CNBC ...
The recent FDA approval of Eli Lilly’s new immunotherapy ... Dr Howard Fillit, co-founder and chief science officer of the Alzheimer’s Drug Discovery Foundation (ADDF) described the latest ...
The first drug found to slow down Alzheimer’s is to be given the green light for use in Britain. Lecanemab, hailed by experts as “the beginning of the end” for the disease, has been found to ...
AC Immune said its partner Life Molecular Imaging received fast-track designation from the U.S. Food and Drug Administration ... conditions: Alzheimer's disease, progressive supranuclear palsy ...
The first drug found ... for Alzheimer’s. “It slows the disease. Slows it by about 25 to 30 per cent,” he said. “So, you know, maybe if in the old days you were going to get five years ...
Feedback